Concentrations of metronidazole in human plasma and saliva after tablet or gel administration
- 6 November 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 66 (1) , 40-47
Abstract
Objectives: The aim of this study was to determine the pharmacokinetic profile of metronidazole (Mtz) tablet and to compare Mtz gel and tablet concentrations in both blood plasma and saliva. Methods: In this randomized cross-over study with a 1-week washout period, 13 volunteers randomly received one (a single oral dose of 750 mg Mtz (Flagyl® – tablet) and 2) 3 g of 15% Mtz benzoate gel (applied by using a dental tray). The HPLC with ultraviolet detection was used to quantify plasma and saliva concentrations of Mtz. The pharmacokinetic parameters (PPs) areas under the curves from 0 to 48 h (AUC0–48) and from 0 to infinity (AUC0–∞), the maximum plasma concentration (Cmax), the time to Cmax, volume of distribution and renal clearance were determined for Mtz tablet. Key findings: Considering the Mtz tablet, plasma showed higher Mtz concentration from 6 to 24 h after drug administration and the highest values concerning AUC0–48h and AUC0–∞ than those obtained in saliva (P < 0.05). No significant differences were observed between plasma and saliva concentrations for Mtz gel. Conclusions: The study showed that some PPs were higher in plasma (P < 0.05) than in saliva concerning Mtz tablet. Gel formulation had similar Mtz bioavailability in plasma and saliva resulting in systemic absorption.Keywords
Funding Information
- São Paulo Research Foundation (#2006/01492-0, #2006/0898-9)
This publication has 38 references indexed in Scilit:
- Metronidazole alone or with amoxicillin as adjuncts to non‐surgical treatment of chronic periodontitis: a 1‐year double‐blinded, placebo‐controlled, randomized clinical trialJournal of Clinical Periodontology, 2012
- Microbiological changes associated with four different periodontal therapies for the treatment of chronic periodontitisOral Microbiology and Immunology, 2008
- Effect of High‐Dose Metronidazole on Pharmacokinetics of Oral Budesonide and Vice Versa: A Double Drug Interaction StudyThe Journal of Clinical Pharmacology, 2007
- Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1‐year resultsJournal of Clinical Periodontology, 2007
- Effects of metronidazole plus amoxicillin as the only therapy on the microbiological and clinical parameters of untreated chronic periodontitisJournal of Clinical Periodontology, 2006
- Oral Health Impacts on Daily Living Related to Four Different Treatment Protocols for Chronic PeriodontitisJournal of Periodontology, 2005
- Adjunctive benefits of systemic amoxicillin and metronidazole in non‐surgical treatment of generalized aggressive periodontitis: a randomized placebo‐controlled clinical trialJournal of Clinical Periodontology, 2005
- Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population II – microbiological resultsJournal of Clinical Periodontology, 2005
- Metronidazole concentrations in plasma, saliva and periodontal pockets in patients with periodontitisJournal of Clinical Periodontology, 2005
- Effects of Metronidazole on Periodontal Treatment NeedsJournal of Periodontology, 1991